Abstract-This study examined the convergent construct validity of a new performance-based assessment instrument called the Comprehensive High-Level Activity Mobility Predictor (CHAMP) as a measure of high-level mobility in servicemembers (SMs) with traumatic lower-limb loss (LLL). The study was completed by 118 SMs. Convergent construct validity of the CHAMP was established using the 6-minute walk test (6MWT) as a measure of overall mobility and physical function and the Amputee Mobility Predictor (AMP) as a measure of basic prosthetic mobility. The known group methods construct validity examined disparities in high-level mobility capability among SMs with different levels of LLL. The CHAMP score demonstrated a strong positive relationship between 6MWT distance (r = 0.80, p < 0.001) and AMP score (r = 0.87, p < 0.001), respectively. In addition, the CHAMP can discriminate between different levels of LLL. Study findings support the CHAMP as a valid performance-based assessment instrument of high-level mobility for SMs with traumatic LLL.
INTRODUCTION
Mobility is defined by the International Classification of Functioning, Disability, and Health (ICF) as moving by changing body position or location or by transferring from one place to another by carrying, moving, or manipulating objects by walking, running, or climbing, and by using various forms of transportation [1] . Using the ICF mobility definition as a foundation and considering the study population being examined, which is servicemembers (SMs) with traumatic lower-limb loss (LLL), we defined "high-level mobility" as advanced-rank function involving change in body position or location by transferring from one place to another by rapidly walking or running. The U.S. Army defines several physical performance factors required for mobility, such as balance, postural stability, coordination, power, speed, and agility [2] . The most appropriate units of measure to quantify the combination of physical performance factors identified for mobility are time and distance, where a decrease in time to cover a specific distance is an indicator of increased mobility and is often associated with improved function [3] . Consequently, multidirectional agility tasks that require greater power and speed of movement similar to the demands on the musculoskeletal system associated with athletic or military maneuvers would be considered high-level mobility.
Existing literature lacks research utilizing performance-based outcome measures to examine high-level mobility differences between varying levels of LLL that include people with unilateral and bilateral amputation [4] . Self-report-based outcome measures, such as questionnaires, found the majority of people with amputation, regardless of level of amputation or number of limbs lost, had little to no difficulty walking on a level-surface, but differences emerged with difficult tasks such as fast walking, inclined ambulation, and stairs [4] [5] [6] . Whereas self-report outcome measures are ideal for determining an individual's perception of his or her function when direct observation is not possible [7] [8] [9] [10] , the qualification or self-appraisal of higher-level mobility can be vague and vary greatly, and therefore we determined to employ only performance-based measures to adequately quantify the person with amputation's physical capabilities with a prosthesis.
The current issue with clinically appropriate performance-based outcome measures for the amputee population is that the vast majority of outcome measures are designed for lower levels of mobility, frequently targeting patients during early rehabilitation or the geriatric population [11] [12] [13] [14] [15] . The few tests that assess high-level mobility target athletes during the sport reentry phase of rehabilitation, which requires sprinting skills, hopping, and other maneuvers that would not be appropriate for healing tissues [16] [17] [18] [19] . Moreover, specific higher-level tests are not comprehensive in nature and test only one plane of motion or skill. Many people who experience limb loss as a result of trauma are employed in high-risk professions such as the military, firefighting, and law enforcement. Some would like to return to their chosen professions but must demonstrate to themselves and others that they can do so without putting themselves and others at risk.
The Comprehensive High-Level Activity Mobility Predictor (CHAMP) was created to measure high-level mobility in SMs with traumatic LLL. To be useful as an outcome measure for this unique population, the CHAMP had to quantify and measure change in function throughout the rehabilitation process and provide information relevant in determining readiness to return to high-level activity. In a previously reported study, the CHAMP demonstrated excellent test-retest and interrater reliability in a population of SMs with traumatic LLL [20] . Having established the CHAMP's reliability, it was necessary to validate the CHAMP to establish the degree of confidence that can be placed on inferences made about SMs with amputation's high-level mobility performance [21] .
It was impossible to examine the criterion validity of the CHAMP because no "gold-standard" measure of high-level mobility had been identified. However, it was possible to explore convergent construct validity by examining the relationship between CHAMP scores and established measures of mobility in the amputee population, such as the 6-minute walk test (6MWT) and Amputee Mobility Predictor (AMP). We assumed that as mobility and overall function improves throughout the healing and rehabilitation process, CHAMP scores would increase along with greater distance ambulated in 6 min and higher AMP scores. Therefore, if the CHAMP is a valid measure of high-level mobility, it should be strongly correlated with the 6MWT and AMP.
The 6MWT is considered a measure of overall mobility, endurance, and physical functioning in the adult and geriatric population and has been described as a physical performance measure of functional ambulation in people with LLL [22] [23] . The AMP has been shown to be a measure of basic mobility in people with LLL [20] . Both the 6MWT and the AMP have excellent reliability for people with LLL and can differentiate between Medicare Functional Classification Levels (MFCLs) [20] .
The MFCL is an index designed for the association between the mobility of a person with limb loss and the prosthetic foot and/or knee component prescription that theoretically would best match functional ability. When the AMP scoring system was developed, no reason existed to exceed the five categories of the MFCL. However, as rehabilitation strategies and prosthetic components improved over time, so did the expectations of physical performance for people with limb loss. At Walter Reed Army Medical Center (WRAMC), the majority of SMs with limb loss were achieving high scores on the AMP early in the rehabilitation process after receiving a prosthesis, and a ceiling was observed [24] . The physical capabilities of SMs has improved to the level that approximately 17 percent of those with limb loss either qualified for Continuation on Active Duty or Continuation on Active Reserve, or were determined to be Fit for Duty [25] [26] . There was a clear need for a measure of performance beyond the AMP. The 6MWT does not have a maximum distance but is limited to walking in a single direction and does not permit running. We determined that a need existed for a clinically friendly performancebased test that could quantify the ability to move in all three planes of motion, may be implemented during early rehabilitation, could be performed by walking or sprinting, did not require any hopping, and would include the skills necessary for military or similar physically demanding professions or sports regardless of age.
The CHAMP, as a performance-based outcome measure, should objectively determine whether differences in high-level mobility capabilities exist between SMs with different level of amputation. The ability to determine differences in mobility between the level(s) and number of limbs amputated would help determine realistic goals for the clinician and SM. For example, clinicians could outline rehabilitation programs that focused on improving multidirection mobility, with practical expectations for the lower and upper limits of mobility, in SMs with either unilateral or bilateral amputation and for specific levels of amputation. Objectives for all concerned could be obtained with less frustration, based on unobtainable goals not being met or the SM not completing rehabilitation with a sense of failure, because they have a measure of high-level mobility with which they could gauge their individual capabilities.
The purpose of this study was to examine the convergent construct validity of the CHAMP as a measure of high-level mobility based on the performance of SMs with traumatic LLL. We hypothesized that if the CHAMP was a valid measure of high-level mobility in SM with limb loss, CHAMP scores would correlate with the 6MWT distance and AMP scores and differ among the levels of amputation.
METHODS

Study Design
This cross-sectional, multisite study was conducted at WRAMC in Washington, DC; Center for the Intrepid at Brooke Army Medical Center (BAMC), San Antonio, Texas; and Womack Army Medical Center, Fort Bragg, North Carolina. We studied a sample of 118 SMs with LLL. Participants were either Active Duty or retired male SMs between the ages of 18 and 40 yr with traumatic LLL characterized by level as unilateral transtibial amputation (TTA), unilateral transfemoral amputation (TFA), bilateral transtibial amputation (BTTA), bilateral transfemoral amputation (BTFA), or a combination of transtibial and transfemoral amputation (TTA/TFA). Participants were medically stable with a properly fitting prosthesis and demonstrated a minimal level of function defined as an AMP score of at least 37 points and/or 6MWT of at least 250 m. Five participants (four with BTFA and one with TTA/TFA) scored less than 37 on the AMP (either a 32 or 35). Because these SMs all ambulated greater than 250 m in 6 min, they were included in the study sample. Participants were excluded if they had spinal cord injury; upper-limb loss; peripheral nerve injury limiting function; orthopedic, cardiopulmonary, or contralateral limb injuries limiting mobility or exercise tolerance; or inability to follow commands or physical limitations because of traumatic brain injury (TBI). All participants had been evaluated at the medical treatment facilities with the most current evaluation procedure for TBI available at the time of their rehabilitation, and a military physical therapist completed their medical history interview prior to testing to ensure that TBI or other medical conditions were not an issue. Although TBI had been evaluated postinjury and throughout the rehabilitation process by military medical personnel, the effects of TBI were not further quantified or screened for beyond the subjective interview at the time of testing. All participants could follow commands and did not present with observable upper motor neuron complications that would impede physical performance.
Study Procedures
Prior to signing Institutional Review Board-approved informed consent and protected health information forms, a research investigator reviewed and explained to each participant eligibility criteria, methodology, confidentiality, and potential risks involved.
The participants were tested on one occasion and were required to wear their daily-use prosthesis and standard physical training gear (T-shirt, shorts, socks, and sneakers). Two physical therapists who were currently working or had previously worked in the Armed Forces Amputee Patient Care Program Rehabilitation Centers at WRAMC and BAMC interviewed the participants. Information such as demographic characteristics, current medical conditions, symptoms, and pain and anthropometric measurements such as height, body mass, and waist circumference were collected for all participants.
Outcome Measures
Comprehensive High-Level Activity Mobility Predictor
The four tests that make up the CHAMP are the Single Limb Stance (SLS), Edgren Side Step Test (ESST), TTest, and Illinois Agility Test (IAT) [27] [28] [29] [30] [31] [32] [33] [34] . Testing was administered either outdoors on a smooth surface under a covered patio or indoors within a gymnasium on a hardwood floor. Teams of two raters observed the participants from separate unobstructed vantage points. Each participant performed the CHAMP independently to avoid competition. A seated rest period of up to 2 min between each CHAMP item was required. Participants were asked to perform each test twice, with the best score of the two trials selected for data analysis. In the event a participant was unable to successfully complete a test in two trials because of a disqualification or a fall, a third trial was permitted. To maintain consistency, we determined prior to testing to utilize the data from one rater for analysis of CHAMP performance. The best times/points reported by the selected rater for each individual CHAMP item (SLS, ESST, T-Test, and IAT) were converted to a 0-10 scoring system, with higher scores indicating better performance. The scores for each individual test were added together to produce a composite CHAMP score with a 0-40 scoring range. Higher scores indicated better performance on the CHAMP [27] .
6-Minute Walk Test
The 6MWT is a measure of overall functional mobility and cardiopulmonary and musculoskeletal endurance. Two different research staff members administered it at each testing site after each participant completed the CHAMP test. A rest period of 10 min was given to each participant prior to beginning the 6MWT. The 6MWT was performed indoors on a smooth, flat surface. Administration of the 6MWT was largely consistent with recommendations by the American Thoracic Society (ATS). The participants were reminded that the 6MWT was "not a cool down" and were given standardized instructions consistent with ATS guidelines that encouraged the participant "to cover as much distance as possible," which included a demonstration of the task. The track distance (200 ft/61 m to 212 ft/65 m) and rectangular shape eliminated the need to perform a pivot turn and allowed participants to circle the course without interruption of cadence [35] . The course configuration was consistent and was not considered a source of variability in performance [36] . At the completion of the 6MWT, the distance walked was measured and recorded in meters.
Amputee Mobility Predictor
The AMP was administered by the same research investigator and licensed physical therapist at all three data collection sites. It was performed indoors on a flat surface and administered as previously described [6] . The AMP contains 20 items progressing in level of difficulty: items 1 and 2 test the participant's ability to maintain sitting balance unsupported and reaching; items 3 through 7 examine the participant's ability to maintain balance while performing chair-to-chair transfers, sit-to-stand activities, and maintenance of quiet standing; items 8 through 13 are more challenging activities related to standing balance that include single-limb stance, modified reach test, nudge test, picking an object up from the floor, and standing with eyes closed; and items 14 through 20 evaluate various components of gait such as gait initiation, step length, step continuity, ability to vary cadence, transverse over an obstacle, turns, and ascending and descending stairs. All item scores were added together to produce an AMP score for each individual.
Statistical Analysis
Statistical analyses were performed using SAS version 9.1 (SAS Institute Inc; Cary, North Carolina). Descriptive statistics were used to characterize the study sample. The convergent construct validity of the CHAMP was examined by calculating a Pearson product-moment correlation coefficient to determine the strength and direction of the relationship between the CHAMP score and 6MWT distance. The relationship between the CHAMP and AMP was also determined with the intention of ascertaining whether a continuum of mobility could be established with a basic mobility and high-level mobility measure.
Frequency distribution data were analyzed to determine the number of SMs with LLL who performed in the range of SMs without LLL for the CHAMP items and CHAMP score. CHAMP performance data for SMs without LLL, which were previously collected when establishing the reliability of the CHAMP, were used for this analysis [27] .
The construct validity of the CHAMP was established using the known group methods. Analysis of variance (ANOVA), followed by post hoc Tukey honestly significant differences, was calculated to compare CHAMP item scores and total CHAMP score among those with TTA, TFA, and bilateral lower-limb amputation (BLLA).
RESULTS
The baseline characteristics of the 118 participants are described in Table 1 , which includes mean age, height, body mass, time since injury, and military status at time of testing. Of note, 60 participants had TTA, 32 had TFA, 26 had BLLA (12 had BTTA, 7 had BTFA, and 7 had TTA/TFA). Of the participants, 42 (36%) had completed skilled rehabilitation, 32 had returned to Active Duty (27%), and 44 (37%) had retired from the Armed Forces.
Common medical comorbidities reported by the SMs with LLL are listed in Table 2 . On the day of testing, prior to performing the CHAMP, all participants completed a visual analog scale (10 mm scale with 0 = no pain to 10 = worst pain imaginable), to assess pain in the upper and lower limb, neck, back, and residual limb. All participants responded with "0" or no pain.
The mean ± standard deviation (SD) for the 6MWT distance for all participants was 598.1 ± 108.5 m with a minimum and maximum ambulation distance of 264.1 m and 857.9 m, respectively. The average ambulated was consistent or exceeded that of MFCL K-level-4 for people with LLL, which is typical for active adults and athletes [22] . Differences in 6MWT distance were found between participants with TTA, TFA, and BLLA, but not between those with TFA and BLLA ( Table  3) . The CHAMP score demonstrated a strong positive relationship with 6MWT distance (r = 0.80, p < 0.001).
The results indicate that high CHAMP scores correlated with greater distance ambulated in 6 min. The mean ± SD for AMP performance for all participants was 43.8 ± 3.1 points, with a minimum and maximum score of 32 and 47, respectively. Differences in AMP performance were found between the three primary amputation groups ( Table 3) . The mean ± SD for the CHAMP score was 21.9 ± 7.8, with a minimum and maximum score of 1 and 35, respectively. The CHAMP score demonstrated a strong positive relationship with AMP performance (r = 0.87, p < 0.001), indicating that high CHAMP scores correlated with high AMP scores.
The range of CHAMP item and total scores for SMs with limb loss overlapped with those of SM without limb loss ( Table 4) . The SMs without LLL were tested previously and were used to establish the reliability of the CHAMP [27] . Three SMs with TTA (5%) scored within the range of SMs without limb loss for SLS. Thirty-two SMs with TTA (53%) and three with BTTA (25%) scored within the range of SMs without limb loss for the ESST. Thirty-three SMs with TTA (55%) and two with BTTA (16%) scored within the range of SMs without limb loss for the T-Test. Thirty-seven SMs with TTA (62%) and one with BTTA (8%) scored within the range SMs without limb loss for the IAT. Three SMs with TTA (5%) demonstrated CHAMP total scores that were within the range of SMs without limb loss.
ANOVA was used to compare differences in CHAMP item and CHAMP total scores by level of LLL ( Table 5) . Differences in SLS times were found between those with unilateral and bilateral LLL (p < 0.001), but when grouped by amputation level, the TTA and TFA groups with unilateral or bilateral LLL did not differ significantly. The ESST and IAT scores differed significantly between the TTA and TFA groups (p < 0.05) and between the TTA and BLLA groups (p < 0.05). There were significant differences among all three groups for both the T-Test and CHAMP score (p < 0.05). When examining by different levels of bilateral LLL, significant differences in CHAMP score were found between and within all levels of LLL (p < 0.05) except for those with TFA and BTTA ( Table 4) .
DISCUSSION
The CHAMP has been found to be a safe and reliable performance-based outcome measure that assesses highlevel mobility capabilities in SMs with traumatic LLL [27] . The purpose of this study was to determine the construct validity of the CHAMP with two methods: first, by examining the convergent validity between CHAMP score and outcome measures that assess a similar construct and second, by using the known groups methods to determine differences in high-level mobility, as measured by the CHAMP score, between SMs with different levels of amputation.
The convergent validity of the CHAMP was established using the 6MWT as a measure of overall mobility and physical function in people with LLL [22] [23] [37] [38] . 6MWT performance has not been reported in the literature for a population of young fit males with traumatic LLL. The range in 6MWT performance (264-858 m) in Table 5 .
Comparison of Comprehensive High-Level Activity Mobility Predictor (CHAMP) test items and CHAMP total score performance between three levels of amputation. Note: Significant difference was set to p  0.05. * Significant difference between those with TTA and BLLA. † Significant difference between those with TFA and BLLA. ‡ Significant difference between those with TTA and TFA.
BLLA = bilateral lower-limb amputation, ESST = Edgren Side
Step Test, IAT = Illinois Agility Test, SD = standard deviation, SLS = Single Limb Stance, TFA = unilateral transfemoral amputation, TTA = unilateral transtibial amputation.
this study indicated that, regardless of amputation or number of lower limbs lost, this population of wellrehabilitated SMs has the walking capacity consistent with civilian community ambulators to nondisabled peers at the highest fitness levels [39] [40] . We anticipated that SMs who scored poorly on the CHAMP would walk a shorter distance in the 6MWT. Conversely, those with higher CHAMP scores indicating greater high-level mobility would ambulate greater distances in 6 min. The study results support these assumptions and validate the CHAMP as a measure of high-level mobility based on the strong positive correlation between 6MWT distance and CHAMP score. Like the 6MWT, AMP performance has never been reported in the literature for a population of young SMs with traumatic LLL. We determined that an AMP score of 37 or better implies that, if the person with amputation is demonstrating proficient balance, postural stability, prosthetic control during sitting and standing, as well as the ability to vary walking cadence, he or she is ready to perform activities beyond basic locomotion [22] . The AMP was designed to measure function within the MFCL classification system, and therefore a ceiling effect for high-level activity was expected for those who exhibit functional mobility beyond the highest K-level, K-level-4. The CHAMP and AMP demonstrated such a strong, positive correlation (r = 0.87, p < 0.001) because we had subject variability as per functional capabilities, level of amputation, and time since amputation, resulting in a wide variance in both AMP (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) and CHAMP (1-35) performance. We had participants who scored on the lower end of the AMP who walked the CHAMP to those who reached maximum scores on the AMP (47) and scored within the normal range of their nondisabled peers in the CHAMP (>33). Only two participants (both with TTA) scored maximum on the AMP and greater than a 33 on the CHAMP (34 and 35). More importantly, there was an area of overlap in performance where SMs have not achieved maximum scores on the AMP but can perform the CHAMP safely. While the AMP is a measure of basic mobility, the CHAMP is an appropriate measure of high-level mobility based on its component items. Because the CHAMP is designed to be performed with or without assistive devices, speed would be relative to each individual's mobility potential, where walking, jogging, or running would be acceptable. Together, these two instruments can provide clinicians with a continuum of performance-based assessment as the patients with LLL progress through the rehabilitation process. People with amputation who demonstrate higher AMP scores (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) have adequate balance with both static and lower-level dynamic activities, demonstrate better than average lower-limb power, and show competent use of their prosthesis. Once these patients have demonstrated these skills, they could be administered the CHAMP. As improvement in prosthetic ambulation and function occurs, the patients should begin to demonstrate the ability to perform higher-level activities such as stopping and starting movement, changing directions, and moving in multiple planes at a greater speed. As they continue to progress, the level of performance in terms of efficiency, coordination, speed, and agility should improve, resulting in higher CHAMP scores.
Performance-based measures of abilities that exceed those required for general mobility need to be available to assess those people with LLL who demonstrate advanced ambulation and mobility capabilities such as the ability to run and perform agility skills consistent with high level recreational activities, sports, and physically demanding jobs. Examples of those professions are those who serve in the military, firefighters, law enforcement officers, and professional athletes. The findings of this study demonstrated that a percentage of SMs with limb loss were able to achieve CHAMP scores equal to their nondisabled SM peers. The results support the CHAMP as a suitable measure of high-level mobility for people who have exceeded the AMP's ability to measure functional mobility and defined by the MFCLs.
Interestingly, almost half of those with TTA and a few with BTTA performed individual CHAMP items at the level of SMs without limb loss. For those with TTA or BTTA, the knee joint and subsequent use of the surrounding musculature can be used appropriately in performance of high-level mobility activities generating fast and explosive movement [41] . The presences of the knee joint enables participants to maintain posture, change directions faster, and maintain balance with greater ease, thus scoring better on all three agility tests. In addition, investigators observed greater use of the prosthesis to assist, rather than hinder, performance in SMs with TTA and BTTA. It appears that preservation of the knee joint(s) helped SMs with TTA and BTTA perform specific CHAMP items at the level of their nondisabled peers.
Differences in CHAMP item scores were not found across all levels of LLL. No differences in SLS were found between participants with unilateral LLL and those with BLLA, suggesting that balance and postural stability impairments affect these participants equally. Differences were not found between those with TFA, BTTA, and TTA/TFA for the ESST, T-Test, and IAT, suggesting that uniplanar, biplanar, and multiplanar movements are equally challenging for these groups. The individuals with TFA and BLLA undergo impairments to body structure and function with the loss of at least one knee joint and potentially two knee joints. Consequently, changes to the surrounding musculature result in alterations with respect to bone and muscle length, muscle size, and number of remaining muscle fibers, which alters the lowerlimb power generation of the residual limb(s) [42] . Diminished lower-limb power generation alters the ability of the person with amputation to perform fast, explosive movements necessary to quickly stop and start motion and change directions and body positions. For example, in order to change directions quickly in the frontal plane when performing the ESST or in the sagittal plane when pivoting such as in the IAT, it is necessary to be able to flex the knee joint and eccentrically contract the quadriceps femoris and gluteus maximus in order to produce a powerful concentric contraction leading to a fast explosive movement. In addition, the intact hamstrings are needed to allow the individual to stabilize the pelvis and lower the center of mass in order to assist with maximum power generation. Individuals with TFA and BLLA such as those with BTFA and TTA/TFA who are missing the knee joint(s) and original insertions of quadriceps femoris and hamstring muscles have to rely on hip adductors and abductors to produce movement in the frontal plane and change directions when pivoting in the sagittal plane, which results in less lower-limb power generation and slower movement. Lastly, because of the inability to flex their prosthetic knee voluntarily, they are unable to take advantage of the energy storage and return properties of carbon fiber prosthetic feet, thus relegating the prosthetic foot to a role of support and not energy production.
Yet when the scores for all four CHAMP items were combined to produce a composite CHAMP score, differences were found between the three main levels of lower limb and nearly all levels of LLL individually. These results support the use of the composite CHAMP score to assess high-level mobility because it provides a comprehensive view of the use physical performance factors of mobility in different planes of motion and under different conditions in SMs with traumatic LLL.
Future work should include exploring the potential of the CHAMP not only as a measure of high-level mobility but also as an instrument to assist with exercise prescription, examining specific movement patterns, determining the contribution of prosthetic components, and other variables that affect overall mobility. In addition, issues such as the effects of TBI, hearing loss, vision, and musculoskeletal issues need to be addressed. For example, while all participants in this study were screened for TBI, the subtle influences of cognition and motor performance on balance and high-activity mobility have not been determined.
CONCLUSIONS
The findings of the present study support the validity of the CHAMP as a comprehensive measure of highlevel mobility in SMs with LLL. The convergent construct validity and known group methods helped established the CHAMP's ability to assess and differentiate high-level mobility capabilities among the sample population. In summary, the CHAMP is a valid comprehensive measure of high-level mobility that assesses the person with amputation's capabilities and discriminates between people with LLL who are functioning at different levels. 
